Clinical Trial Results:
A multi-centre, randomised, dose-ascending, double-blind, placebo-controlled, four-way incomplete block crossover study, to examine efficacy, safety, tolerability, pharmacodynamics and pharmacokinetics of single and repeat administration of three inhaled doses (300, 600, and 1200 mcg once daily) of GSK159802 in asthmatic patients.
Summary
|
|
EudraCT number |
2006-001891-19 |
Trial protocol |
DE |
Global completion date |
24 May 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 Dec 2018
|
First version publication date |
16 Dec 2018
|
Other versions |
|
Summary report(s) |
Cancelled before Active Statement |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.